These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 14559905)
1. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. Swaminath G; Xiang Y; Lee TW; Steenhuis J; Parnot C; Kobilka BK J Biol Chem; 2004 Jan; 279(1):686-91. PubMed ID: 14559905 [TBL] [Abstract][Full Text] [Related]
2. Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. Swaminath G; Deupi X; Lee TW; Zhu W; Thian FS; Kobilka TS; Kobilka B J Biol Chem; 2005 Jun; 280(23):22165-71. PubMed ID: 15817484 [TBL] [Abstract][Full Text] [Related]
3. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. Gether U; Lin S; Kobilka BK J Biol Chem; 1995 Nov; 270(47):28268-75. PubMed ID: 7499324 [TBL] [Abstract][Full Text] [Related]
4. Development and characterization of pepducins as Gs-biased allosteric agonists. Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624 [TBL] [Abstract][Full Text] [Related]
5. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. Bhattacharya S; Hall SE; Li H; Vaidehi N Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472 [TBL] [Abstract][Full Text] [Related]
6. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine. Weitl N; Seifert R J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317 [TBL] [Abstract][Full Text] [Related]
7. Biased Signaling of the G-Protein-Coupled Receptor β Lamichhane R; Liu JJ; White KL; Katritch V; Stevens RC; Wüthrich K; Millar DP Structure; 2020 Mar; 28(3):371-377.e3. PubMed ID: 31978323 [TBL] [Abstract][Full Text] [Related]
8. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234 [TBL] [Abstract][Full Text] [Related]
9. Structural features of β2 adrenergic receptor: crystal structures and beyond. Bang I; Choi HJ Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861 [TBL] [Abstract][Full Text] [Related]
10. Examination of ligand-induced conformational changes in the beta2 adrenergic receptor. Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P Life Sci; 1998; 62(17-18):1509-12. PubMed ID: 9585127 [TBL] [Abstract][Full Text] [Related]
11. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Ghanouni P; Steenhuis JJ; Farrens DL; Kobilka BK Proc Natl Acad Sci U S A; 2001 May; 98(11):5997-6002. PubMed ID: 11353823 [TBL] [Abstract][Full Text] [Related]
13. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. Gether U; Lin S; Ghanouni P; Ballesteros JA; Weinstein H; Kobilka BK EMBO J; 1997 Nov; 16(22):6737-47. PubMed ID: 9362488 [TBL] [Abstract][Full Text] [Related]
14. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579 [TBL] [Abstract][Full Text] [Related]
15. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773 [TBL] [Abstract][Full Text] [Related]
16. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody. Ring AM; Manglik A; Kruse AC; Enos MD; Weis WI; Garcia KC; Kobilka BK Nature; 2013 Oct; 502(7472):575-579. PubMed ID: 24056936 [TBL] [Abstract][Full Text] [Related]
18. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. Zhang J; Barak LS; Winkler KE; Caron MG; Ferguson SS J Biol Chem; 1997 Oct; 272(43):27005-14. PubMed ID: 9341139 [TBL] [Abstract][Full Text] [Related]
19. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. Ghanouni P; Gryczynski Z; Steenhuis JJ; Lee TW; Farrens DL; Lakowicz JR; Kobilka BK J Biol Chem; 2001 Jul; 276(27):24433-6. PubMed ID: 11320077 [TBL] [Abstract][Full Text] [Related]
20. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. Gether U; Ballesteros JA; Seifert R; Sanders-Bush E; Weinstein H; Kobilka BK J Biol Chem; 1997 Jan; 272(5):2587-90. PubMed ID: 9006889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]